← FDA Drug Approvals (Drugs@FDA)

FLUDEOXYGLUCOSE F18

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: KETTERING MEDCTR · Approved 2015-10-27

Drug application

FDA Application #

ANDA204759

Application type

Abbreviated New Drug Application (Generic)

Brand name

FLUDEOXYGLUCOSE F18

Generic name

FLUDEOXYGLUCOSE F-18

Active ingredients

FLUDEOXYGLUCOSE F-18

Dosage form

INJECTABLE

Route

INTRAVENOUS

Marketing status

Prescription

Sponsor

KETTERING MEDCTR

Manufacturer

Kettering Medical Center

First approval

2015-10-27

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown